References
- Rudin CM , PoirierJT. Small-cell lung cancer in 2016: shining light on novel targets and therapies. Nat. Rev. Clin. Oncol.14(2), 75–76 (2017).
- Sen T , GayCM , ByersLA. Targeting DNA damage repair in small cell lung cancer and the biomarker landscape. Transl. Lung Cancer Res.7(1), 50–68 (2018).
- Gazdar AF , BunnPA , MinnaJD. Small-cell lung cancer: what we know, what we need to know and the path forward. Nat. Rev. Cancer17(12), 725–737 (2017).
- Van Meerbeeck JP , FennellDA , DeRuysscher DKM. Small-cell lung cancer. Lancet378(9804), 1741–1755 (2011).
- Peifer M , Fernández-CuestaL , SosMLet al. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer. Nat. Genet.44(10), 1104–1110 (2012).
- George J , LimJS , JangSJet al. Comprehensive genomic profiles of small cell lung cancer. Nature524(7563), 47–53 (2015).
- Wagner AH , DevarakondaS , SkidmoreZLet al. Recurrent WNT pathway alterations are frequent in relapsed small cell lung cancer. Nat. Commun.9(1), 3787 (2018).
- Rudin CM , DurinckS , StawiskiEWet al. Comprehensive genomic analysis identifies SOX2 as a frequently amplified gene in small-cell lung cancer. Nat. Genet.44(10), 1111–1116 (2012).
- Yokomizo A , TindallDJ , DrabkinHet al. PTEN/MMAC1 mutations identified in small cell, but not in non-small cell lung cancers. Oncogene17(4), 475–479 (1998).
- Rudin CM , PoirierJT , ByersLAet al. Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat. Rev. Cancer19(5), 289–297 (2019).
- Chang HY . Genome regulation by long non-coding RNAs. Blood122(21), SCI-29 (2013).
- Morris KV , MattickJS. The rise of regulatory RNA. Nat. Rev. Genet.15(6), 423–437 (2014).
- Derrien T , JohnsonR , BussottiGet al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res.22(9), 1775–1789 (2012).
- Cabili M , TrapnellC , GoffLet al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev.25(18), 1915–1927 (2011).
- Wu T , DuY. LncRNAs: from basic research to medical application. Int. J. Biol. Sci.13(3), 295–307 (2017).
- Schmitt AM , ChangHY. Long noncoding RNAs in cancer pathways. Cancer Cell29(4), 452–463 (2016).
- Salzman J , GawadC , WangPL , LacayoN , BrownPO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE7(2), e30733 (2012).
- Barrett SP , WangPL , SalzmanJ. Circular RNA biogenesis can proceed through an exon-containing lariat precursor. Elife4(JUNE), 1–18 (2015).
- Suzuki H , TsukaharaT. A view of pre-mRNA splicing from RNase R resistant RNAs. Int. J. Mol. Sci.15(6), 9331–9342 (2014).
- Meng X , LiX , ZhangP , WangJ , ZhouY , ChenM. Circular RNA: an emerging key player in RNA world. Brief. Bioinform.18(4), 547–557 (2017).
- Barrett SP , SalzmanJ. Circular RNAs: analysis, expression and potential functions. Development143(11), 1838–1847 (2016).
- Chen LL . The biogenesis and emerging roles of circular RNAs. Nat. Rev. Mol. Cell Biol.17(4), 205–211 (2016).
- Zhong Y , DuY , YangXet al. Circular RNAs function as ceRNAs to regulate and control human cancer progression. Mol. Cancer17(1), 1–11 (2018).
- Vo JN , CieslikM , ZhangYet al. The landscape of circular RNA in cancer. Cell176(4), 869–881.e13 (2019).
- Qian L , YuS , ChenZ , MengZ , HuangS , WangP. The emerging role of CircRNAs and their clinical significance in human cancers. Biochim Biophys Acta Rev Cancer1870(2), 247–260 (2018).
- Lei B , TianZ , FanW , NiB. Circular RNA: a novel biomarker and therapeutic target for human cancers. Int. J. Med. Sci.16(2), 292–301 (2019).
- Zhang C , MaL , NiuYet al. Circular RNA in lung cancer research: biogenesis, functions, and roles. Int. J. Biol. Sci.16(5), 803–814 (2020).
- Tsai M-C , ManorO , WanYet al. Long noncoding RNA as modular scaffold of histone modification complexes. Science329(5992), 689–693 (2010).
- Ono H , MotoiN , NaganoHet al. Long noncoding RNA HOTAIR is relevant to cellular proliferation, invasiveness, and clinical relapse in small-cell lung cancer. Cancer Med.3(3), 632–642 (2014).
- Sun Y , ZhouY , BaiYet al. A long non-coding RNA HOTTIP expression is associated with disease progression and predicts outcome in small cell lung cancer patients. Mol. Cancer16(1), 1–15 (2017).
- Wang KC , YangYW , LiuBet al. A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression. Nature472(7341), 120–126 (2011).
- Sun Y , HuB , WangQet al. Long non-coding RNA HOTTIP promotes BCL-2 expression and induces chemoresistance in small cell lung cancer by sponging miR-216a. Cell Death Dis.9(2), 85 (2018).
- Wang D , WuW , HuangW , WangJ , LuoL , TangD. LncRNA LUADT1 sponges miR-15a-3p to upregulate Twist1 in small cell lung cancer. BMC Pulm. Med.19(1), 1–6 (2019).
- Huang C , LiuS , WangH , ZhangZ , YangQ , GaoF. LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer. Am. J. Transl. Res.8(11), 5025–5034 (2016).
- Zeng F , WangQ , WangSet al. Linc00173 promotes chemoresistance and progression of small cell lung cancer by sponging miR-218 to regulate Etk expression. Oncogene39(2), 293–307 (2020).
- Chen S , WuH , LvNet al. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer. Biomed. Pharmacother.82, 583–588 (2016).
- Chen W , HangY , XuWet al. BLACAT1 predicts poor prognosis and serves as oncogenic lncRNA in small-cell lung cancer. J. Cell. Biochem.120(2), 2540–2546 (2019).
- Wu L , WangP. Long non-coding rna-neighboring enhancer of foxa2 inhibits the migration and invasion of small cell lung carcinoma cells by downregulating transforming growth factor-β1. Oncol. Lett.17(6), 4969–4975 (2019).
- Fu Y , ZhangP , NanHet al. LncRNA CASC11 promotes TGF-β1, increases cancer cell stemness and predicts postoperative survival in small cell lung cancer. Gene704(November 2018), 91–96 (2019).
- Niu Y , MaF , HuangWet al. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2. Mol. Cancer16(1), 1–13 (2017).
- Zhang Y , LiY , HanL , ZhangP , SunS. SBF2-AS1: an oncogenic lncRNA in small-cell lung cancer. J. Cell. Biochem.120(9), 15422–15428 (2019).
- Yan Z , YangQ , XueM , WangS , HongW , GaoX. YY1-induced lncRNA ZFPM2-AS1 facilitates cell proliferation and invasion in small cell lung cancer via upregulating of TRAF4. Cancer Cell Int.20(1), 1–11 (2020).
- Zhu QQ , MaC , WangQ , SongY , LvT. The role of TWIST1 in epithelial-mesenchymal transition and cancers. Tumor Biol.37(1), 185–197 (2016).
- Chang Z , CuiJ , SongY. Long noncoding RNA PVT1 promotes EMT via mediating microRNA-186 targeting of Twist1 in prostate cancer. Gene654(February), 36–42 (2018).
- Zhan T , RindtorffN , BoutrosM. Wnt signaling in cancer. Oncogene36(11), 1461–1473 (2017).
- Ling H , SpizzoR , AtlasiYet al. CCAT2, a novel noncoding RNA mapping to 8q24, underlies metastatic progression and chromosomal instability in colon cancer. Genome Res.23(9), 1446–1461 (2013).
- Wang CH , LiYH , TianHL , BaoXX , WangZM. Long non-coding RNA BLACAT1 promotes cell proliferation, migration and invasion in cervical cancer through activation of Wnt/β-catenin signaling pathway. Eur. Rev. Med. Pharmacol. Sci.22(10), 3002–3009 (2018).
- Padua D , MassaguéJ. Roles of TGFβ in metastasis. Cell Res.19(1), 89–102 (2009).
- Cao R , WangL , WangHet al. Role of histone H3 lysine 27 methylation in polycomb-group silencing. Science298(5595), 1039–1043 (2002).
- Yu H , ZhengJ , LiuXet al. Transcription factor NFAT5 promotes glioblastoma cell-driven angiogenesis via SBF2-as1/mIR-338-3p-mediated EGFl7 expression change. Front. Mol. Neurosci.10(September), 1–15 (2017).
- Fang S , GaoH , TongYet al. Long noncoding RNA-HOTAIR affects chemoresistance by regulating HOXA1 methylation in small cell lung cancer cells. Lab. Investig.96(1), 60–68 (2016).
- Fang S , ShenY , ChenBet al. H3K27me3 induces multidrug resistance in small cell lung cancer by affecting HOXA1 DNA methylation via regulation of the lncRNA HOTAIR. Ann. Transl. Med.6(22), 440–440 (2018).
- Chen R , ChenB , LiDet al. HOTAIR contributes to chemoresistance by activating NF-κB signaling in small-cell lung cancer. Int. J. Clin. Exp. Pathol.12(8), 2997–3004 (2019).
- Kuang P , ChenP , WangLet al. RNA sequencing analysis of small cell lung cancer reveals candidate chemotherapy insensitivity long noncoding RNAs and microRNAs. Ann. Transl. Med.8(4), 121–121 (2020).
- Wang S , YuJ. Long non-coding RNA transcribed from pseudogene PPIAP43 is associated with radiation sensitivity of small cell lung cancer cells. Oncol. Lett.18(5), 4583–4592 (2019).
- Li L , SongW , YanXet al. Friend leukemia virus integration 1 promotes tumorigenesis of small cell lung cancer cells by activating the miR-17-92 pathway. Oncotarget8(26), 41975–41987 (2017).
- Li L , LiW , ChenNet al. FLI1 exonic circular RNAs as a novel oncogenic driver to promote tumor metastasis in small cell lung cancer. Clin. Cancer Res.25(4), 1302–1317 (2019).
- Schofield AV , BernardO. Rho-associated coiled-coil kinase (ROCK) signaling and disease. Crit. Rev. Biochem. Mol. Biol.48(4), 301–316 (2013).
- Huang W , YangY , WuJet al. Circular RNA cESRP1 sensitises small cell lung cancer cells to chemotherapy by sponging miR-93-5p to inhibit TGF-β signalling. Cell Death Differ.27(5), 1709–1727 (2020).
- Zhang C , ZhangB , YuanBet al. RNA-Seq profiling of circular RNAs in human small cell lung cancer. Epigenomics12(8), 685–700 (2020).
- Rolfo C , MackPC , ScagliottiGVet al. Liquid Biopsy for advanced non-small cell lung cancer (NSCLC): a statement paper from the IASLC. J. Thorac. Oncol.13(9), 1248–1268 (2018).
- Revelo AE , MartinA , VelasquezRet al. Liquid biopsy for lung cancers: an update on recent developments. Ann. Transl. Med.7(15), 349 (2019).